Pharmaceutical companies
-
February 16, 2021, Tuesday
Asset monetisation, sales uptick in US key triggers for Glenmark Pharma
The India business is expected to post double digit growth in FY22
-
February 03, 2021, Wednesday
Indegene's valuation reaches $700 mn; raises $200 mn from Carlyle, Brighton
Given the wider adoption of digital initiatives within the healthcare industry, Indegene plans to use the funds to accelerate its ...
-
January 28, 2021, Thursday
Eris Lifesciences Q3 net up 42% to Rs 90 cr, total income rises by 14%
Overall, the company saw decent growth in its product segments, led by cardio metabolic and vitamin-mineral-nutrients
-
-
September 28, 2020, Monday
As domestic sales decline, drug makers focus on exports to sustain growth
During April-July, drug makers exported products worth $ 7.4 billion, a growth of 9.5 per cent on year on year basis
-
September 25, 2020, Friday
GMM Pfaudler says ready to respond to charges on unusual trades during OFS
The stock continues to fall, and is down over 36 per cent since September 15
-
September 24, 2020, Thursday
Export boost to help pharma sector come out unscathed from Covid-19: CRISIL
Exports and domestic formulations account for an almost equal share in the Rs 2.8-trillion domestic pharma sector, CRISIL said
-
September 13, 2020, Sunday
Gilead nears deal to buy Immunomedics for more than $20 billion: Report
Discussions between Gilead and Immunomedics were initially centered around a partnership before shifting to a full-fledged ...
-
September 02, 2020, Wednesday
Zydus Cadila gets approval from USFDA for muscle relaxant injection
Drugfirm Zydus Cadila has received final approval from the US health regulator to market Cisatracurium BesylateInjection, a ...
-
August 30, 2020, Sunday
Covid-19 prescription: Pharma players shift their focus over the counter
The pandemic pushes pharma companies to look at drugs that held promise in transitioning to over the counter segment
